July 23, 2026

Modular Medical engages Thrivable for expanded research focused on people with diabetes who currently utilize multiple daily injections (BioSpace.com – 7/14/26)

Under the engagement, Thrivable will tap into its 140,000+ triple-verified patient panel to conduct in-depth engagement with 20 individuals living with diabetes and deliver a survey with an additional 300 insulin-using patients.

San Diego, CA, July 14, 2026 - Modular Medical, Inc. ("Modular Medical" or "the Company") (NASDAQ:MODD), a commercial-stage medical device company that is commercializing the next generation of insulin delivery technology, today announced positive findings from a new comprehensive diabetes patient research initiative further supporting its commercialization strategy. The Company will share these findings and showcase its Pivot™ tubeless insulin patch pump at the upcoming Association of Diabetes Care & Education Specialists (ADCES) Annual Conference in Columbus, Ohio, August 7-10, 2026.

Read the full press release on BioSpace.com >>

Back to News & Press